Patent: 9,051,582
✉ Email this page to a colleague
Summary for Patent: 9,051,582
Title: | Expression vectors comprising the mCMV IE2 promoter |
Abstract: | The invention relates to an expression vector comprising the promoter of the mCMV-IE2 gene, or a functional expression promoting fragment thereof, and/or an enhancer of the mCMV-IE2 gene, or a functional expression enhancing fragment thereof, wherein the expression vector does not contain any complete gene of the mCMV. |
Inventor(s): | Chatellard; Philippe (Lausanne, CH), Imhof; Markus (Chexbres, CH) |
Assignee: | MERCK SERONO SA (Coinsins, Vaud, CH) |
Application Number: | 12/872,151 |
Patent Claims: | see list of patent claims |
Details for Patent 9,051,582
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | 06/04/1986 | ⤷ Try a Trial | 2023-03-11 |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | ⤷ Try a Trial | 2023-03-11 | |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | Injection | 103132 | ⤷ Try a Trial | 2023-03-11 | |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |